Advertisement
Anesthesiology and Pulmonary Medicine
Subscribe to Anesthesiology and Pulmonary Medicine
View Sample

FREE Email Newsletter

Patients with severe non-inflammatory respiratory disease face anemia risk

March 31, 2011 10:33 am | by EurekAlert | News | Comments

(Wiley-Blackwell) The links between chronic obstructive pulmonary disease and anemia are already well known, but now a study of nearly 600 patients has found that anemia is also frequently found in patients with severe non-inflammatory respiratory diseases.

Syndax Pharmaceuticals Announces Entinostat Data at 102nd Annual American Association for Cancer Research Meeting

March 31, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

WALTHAM, Mass., March 31, 2011 /- Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, today announced 11 posters on entinostat, an oral, highly selective, class I histone deacetylase (HDAC) inhibitor, will be presented at the 102nd Annual American Association for...

Study suggests a relationship between migraine headaches in children and a common heart defect

March 30, 2011 9:31 pm | by EurekAlert | News | Comments

(Elsevier Health Sciences) Roughly 15% of children suffer from migraines, and approximately one-third of these affected children have migraines with aura, a collection of symptoms that can include weakness, blind spots, and even hallucinations. Although the causes of migraines are...

Advertisement

MSA Increases Production of Air-Purifying Respirators to Help Meet Increased Demand from Japan

March 30, 2011 12:35 pm | by Bio-Medicine.Org | News | Comments

PITTSBURGH, March 30, 2011 /- Global safety equipment manufacturer MSA (NYSE: MSA ) said today it has increased production of its air-purifying respirator (APR) line in two U.S. factories in response to greater demand for such products from Japan.  The respirators, which include...

Vertex CF drug candidate shows promising results

March 30, 2011 5:35 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Vertex Pharmaceuticals has announced additional positive results for its experimental therapy for Cystic Fibrosis, called VX-770, which found lung function improved by 17.4 percent in children between 6 and 11 with a specific type of CF.

Mucus: Fighting the war against pollutants

March 30, 2011 5:35 am | by EurekAlert | News | Comments

(American Friends of Tel Aviv University) New Tel Aviv University research has found that mucus, which was thought to protect our bodies against harmful pollutants, in fact may leave our bodies more vulnerable to them. But the discovery may prove useful in enabling some drugs to enter...

Silence Therapeutics' Phase I Atu027 Data Accepted for Presentation at the American Society of Clinical Oncology 2011 Annual Meeting

March 29, 2011 10:33 pm | by Bio-Medicine.Org | News | Comments

LONDON, March 30, 2011 /- Silence Therapeutics plc (AIM: SLN) ("Silence" or the "Company") a leading global RNA interference (RNAi) therapeutics company, announces that interim data from its ongoing Phase I clinical study of Atu027, the Company's lead internal therapeutic candidate, have...

Important Drug Information Notice Regarding Potassium Phosphates Injection, USP, 3 mM/mL Phosphorous; 4. 4 mEq/mL Potassium: 5 mL, 15 mL and 50 mL Single Dose Vials

March 29, 2011 8:35 am | by Bio-Medicine.Org | News | Comments

SHIRLEY, N.Y., March 29, 2011 /- Yesterday American Regent, Inc. issued a letter regarding a product recall from February 2011. The text of the letter follows: Dear Healthcare Professional, Recently, American Regent, Inc. recalled Potassium Phosphates Injection, USP, 5mL Single Dose Vial,...

Advertisement

Important Drug Information Notice Regarding Sodium Thiosulfate Injection, USP, 10% (100mg/mL), 10mL Single Dose Vials and 25% (250mg/mL), 50mL Single Dose Vials

March 29, 2011 8:35 am | by Bio-Medicine.Org | News | Comments

SHIRLEY, N.Y., March 29, 2011 /- Yesterday American Regent, Inc. issued a letter regarding a product recall from February 2011. The text of the letter follows: Dear Healthcare Professional, Recently, American Regent, Inc. recalled Sodium Thiosulfate Injection, USP, 10%, 10mL Single Dose...

Pelvic arterial embolization for postpartum hemorrhage saves lives, preserves uterus

March 29, 2011 4:35 am | by EurekAlert | News | Comments

(Society of Interventional Radiology) Pelvic arterial embolization or PAE, a minimally invasive, life-saving therapy, is a safe and effective treatment for postpartum hemorrhage, say researchers at the Society of Interventional Radiology's 36th Annual Scientific Meeting in Chicago, Ill.

No scalpel: Minimally invasive breakthrough for men?s enlarged prostates improves symptoms

March 29, 2011 4:35 am | by EurekAlert | News | Comments

(Society of Interventional Radiology) A new interventional radiology treatment that blocks blood supply to men's enlarged prostate glands shows comparable clinical results to transurethral resection of the prostate (or TURP), considered the gold standard (or most common) treatment....

Accuray Incorporated to Speak at 10th Annual Needham Healthcare Conference

March 28, 2011 10:35 am | by Bio-Medicine.Org | News | Comments

SUNNYVALE, Calif., March 28, 2011 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today that its management is scheduled to present at the 10th Annual Needham Healthcare Conference in New York City on Tuesday, April 5, 2011 at 10:00 a.m....

Interventional radiologists take lead on reducing disability from dangerous blood clots

March 28, 2011 5:33 am | by EurekAlert | News | Comments

(Society of Interventional Radiology) Deep vein thrombosis, or DVT: it's more than just a one-time complication from taking a long plane ride. The Society of Interventional Radiology wants individuals to know the risk factors for this very serious condition, which can lead to...

Advertisement

Mersana moves anti-cancer drug target along in trials

March 25, 2011 11:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Mersana Therapeutics Inc., a Cambridge cancer therapeutics developer, has begun a Phase 1b extension study of its treatment for second-line gastric cancer and second- and third-line non-small cell lung cancer.

AACR honors eminent researchers

March 25, 2011 11:33 am | by EurekAlert | News | Comments

(American Association for Cancer Research) The American Association for Cancer Research will recognize leading cancer researchers whose work has significantly contributed to progress in the fight against cancer at the AACR 102nd Annual Meeting 2011. Each recipient will present an...

Mersana Therapeutics Initiates Phase 1b Extension Study of XMT-1001 in Gastric Cancer and Non-Small Cell Lung Cancer

March 25, 2011 6:33 am | by Bio-Medicine.Org | News | Comments

CAMBRIDGE, Mass., March 25, 2011 /- Mersana Therapeutics today announced  the initiation of a Phase 1b extension study with its lead cancer product, XMT-1001 , a novel DNA topoisomerase I inhibitor based on the company's Fleximer® polymer conjugate platform, in second-line...

When you cough up green or yellow phlegm you need to be prescribed antibiotics, right?

March 24, 2011 9:34 am | by EurekAlert | News | Comments

(Cardiff University) Prescribing antibiotics for patients with discoloured phlegm caused by acute cough has little or no effect on alleviating symptoms and recovery, a Cardiff University study has found.

Reportlinker Adds Triple Analysis: Colorectal Cancer, Lung Cancer and Lymphoma

March 24, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

NEW YORK, March 24, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Triple Analysis: Colorectal Cancer, Lung Cancer and Lymphoma http://www.reportlinker.com/p0284975/Triple-Analysis-Colorectal-Cancer-Lung-Cancer-and-Lymphoma.html This...

FDA: Michigan Heart-Lung Bypass Machine Manufacturer Enters Into Consent Decree

March 22, 2011 6:36 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., March 22, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today announced that Terumo Cardiovascular Systems Corporation (TCVS) of Ann Arbor, Mich., and two of its officers, Mark A. Sutter, president and chief executive officer, and Mark Lincoln,...

Terumo Cardiovascular Systems Reaches Agreement on Terms of Consent Decree With FDA Regarding Quality System Improvements

March 22, 2011 3:34 am | by Bio-Medicine.Org | News | Comments

ANN ARBOR, Mich., March 22, 2011 /- Terumo Cardiovascular Systems (Terumo CVS), a U.S.-based subsidiary of Terumo Corporation of Tokyo, Japan, today announced it has agreed to the terms of a consent decree with the U.S. Food & Drug Administration (FDA) regarding quality system...

2011 Annual Meeting of the American Academy of Allergy, Asthma & Immunology

March 21, 2011 12:31 pm | by EurekAlert | News | Comments

(NIH/National Institute of Allergy and Infectious Diseases) Scientists supported by NIAID are among those presenting their latest research findings at the AAAAI Annual Meeting. For more than 60 years, NIAID has supported allergy and immunology research at US and international institutions...

CardioMEMS, Inc. Named a TAG Top 10 Innovative Technology Company

March 21, 2011 12:31 pm | by Bio-Medicine.Org | News | Comments

ATLANTA, March 21, 2011 /- CardioMEMS, Inc ., an Atlanta-based medical technology company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body, today announced that it has been chosen as one of the Top 10 Innovative...

Varian Medical Systems to Exhibit New TrueBeamâ„¢ System for Image-Guided Radiotherapy at ChinaMed Exhibition in Beijing

March 21, 2011 4:34 am | by Bio-Medicine.Org | News | Comments

BEIJING, March 21, 2011 / PRNewswire/ -- Varian Medical Systems, Inc. (NYSE: VAR ), the world's leading manufacturer of medical technology for treating cancer with radiotherapy, will showcase the company's new TrueBeam™ system for image-guided radiotherapy and radiosurgery at the...

Bi-Partisan Legislation Introduced Would Repeal Controversial Medicare 'Competitive Bidding' Requirements for Home Medical Equipment

March 18, 2011 12:34 pm | by Bio-Medicine.Org | News | Comments

HARRISBURG, Pa., March 18, 2011 /- Pennsylvania Association of Medical Suppliers (PAMS) today applauded legislation introduced by Congressmen Glenn "GT" Thompson (R-Centre) and Jason Altmire, (D-Allegheny) that would repeal Medicare's controversial competitive bidding program for home...

New targeted drug helps smokers stub it out

March 17, 2011 1:32 pm | by EurekAlert | News | Comments

(Academy of Finland) Researchers working in a research project within the Academy of Finland's Research Program on Substance Use and Addictions have been developing a targeted drug that could aid in smoking reduction therapy.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading